The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
SELLAS Life Sciences Group, Inc(NASDAQ:SLS) 
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a wilms tumor 1 targeting peptide-based cancer immun...
Website: http://www.sellaslifesciences.com
Full Time Employees: 5
Sector: Healthcare
Industry: Biotechnology
SELLAS Life Sciences Group Days Payable Outstanding ttm (DPO)
SELLAS Life Sciences Group Op Cashflow Per Share ttm
SELLAS Life Sciences Group Free Cashflow Per Share ttm
SELLAS Life Sciences Group Cash Per Share ttm
SELLAS Life Sciences Group P/S ratio ttm
SELLAS Life Sciences Group (GAAP) P/E ratio ttm
SELLAS Life Sciences Group P/B ratio ttm
No extra charts and metrics for this ticker.